BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38138114)

  • 1. Role of Probiotics in Preventing Carbapenem-Resistant
    Lee JH; Shin J; Park SH; Cha B; Hong JT; Lee DH; Kwon KS
    Microorganisms; 2023 Dec; 11(12):. PubMed ID: 38138114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing
    Yuan W; Xu J; Guo L; Chen Y; Gu J; Zhang H; Yang C; Yang Q; Deng S; Zhang L; Deng Q; Wang Z; Ling B; Deng D
    Microbiol Spectr; 2022 Dec; 10(6):e0190621. PubMed ID: 36445086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Risk for Carbapenem-Resistant Enterobacteriaceae Colonization in Intensive Care Units after Hospitalization in Emergency Department.
    Salomão MC; Freire MP; Boszczowski I; Raymundo SF; Guedes AR; Levin AS
    Emerg Infect Dis; 2020 Jun; 26(6):1156-1163. PubMed ID: 32267827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
    McConville TH; Sullivan SB; Gomez-Simmonds A; Whittier S; Uhlemann AC
    PLoS One; 2017; 12(10):e0186195. PubMed ID: 29023567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.
    Dinh A; Fessi H; Duran C; Batista R; Michelon H; Bouchand F; Lepeule R; Vittecoq D; Escaut L; Sobhani I; Lawrence C; Chast F; Ronco P; Davido B
    J Hosp Infect; 2018 Aug; 99(4):481-486. PubMed ID: 29477634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work?
    Tiri B; Sensi E; Marsiliani V; Cantarini M; Priante G; Vernelli C; Martella LA; Costantini M; Mariottini A; Andreani P; Bruzzone P; Suadoni F; Francucci M; Cirocchi R; Cappanera S
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32854334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alarming prevalence of community-acquired multidrug-resistant organisms colonization in children with cancer and implications for therapy: A prospective study.
    Thacker N; Pereira N; Banavali SD; Narula G; Vora T; Chinnaswamy G; Prasad M; Kelkar R; Biswas S; Arora B
    Indian J Cancer; 2014; 51(4):442-6. PubMed ID: 26842153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Risk Factors of Carbapenem-resistant
    Kang JS; Yi J; Ko MK; Lee SO; Lee JE; Kim KH
    J Korean Med Sci; 2019 May; 34(18):e140. PubMed ID: 31074254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
    Korach-Rechtman H; Hreish M; Fried C; Gerassy-Vainberg S; Azzam ZS; Kashi Y; Berger G
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 12. Bloodstream Infections in Patients with Rectal Colonization by Carbapenem-Resistant Enterobacteriaceae: A Prospective Cohort Study.
    Chu W; Hang X; Li X; Ye N; Tang W; Zhang Y; Yang X; Yang M; Wang Y; Liu Z; Zhou Q
    Infect Drug Resist; 2022; 15():6051-6063. PubMed ID: 36277248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing
    Wieërs G; Verbelen V; Van Den Driessche M; Melnik E; Vanheule G; Marot JC; Cani PD
    Front Public Health; 2020; 8():578089. PubMed ID: 33763399
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors for gut colonization of carbapenem-resistant Enterobacteriaceae in neonates in a neonatal intensive care unit.
    Singh NP; Choudhury DD; Gupta K; Rai S; Batra P; Manchanda V; Saha R; Kaur IR
    Am J Infect Control; 2018 Jun; 46(6):e31-e35. PubMed ID: 29803234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active surveillance for carbapenem resistant enterobacteriaceae (CRE) using stool cultures as a method to decrease CRE infections in the pediatric intensive care unit (PICU).
    Krupanandan RK; Kapalavai SK; Ekka AS; Balusamy I; Sadasivam K; Nambi P S; Ramachandran B
    Indian J Med Microbiol; 2023; 44():100370. PubMed ID: 37356850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].
    Huang X; Li G; Yi L; Li M; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a risk prediction model of carbapenem-resistant Enterobacteriaceae colonization among patients in intensive care units.
    Song JY; Jeong IS
    Am J Infect Control; 2018 Nov; 46(11):1240-1244. PubMed ID: 29884578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of Carbapenem-Resistant Enterobacterales Colonization Among Intensive Care Unit Patients in a Tertiary Hospital, China.
    Chen SJ; Zhang WQ; Lin YL; Zeng YB; Chen ST; Wu S; Xun Z; Yang B
    Microb Drug Resist; 2023 Dec; 29(12):568-575. PubMed ID: 37733305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City.
    Prasad N; Labaze G; Kopacz J; Chwa S; Platis D; Pan CX; Russo D; LaBombardi VJ; Osorio G; Pollack S; Kreiswirth BN; Chen L; Urban C; Segal-Maurer S
    Am J Infect Control; 2016 May; 44(5):525-32. PubMed ID: 26796684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital mortality and one-year survival of critically ill patients with cancer colonized or not with carbapenem-resistant gram-negative bacteria or vancomycin-resistant enterococci: an observational study.
    Junior APN; Del Missier GM; Praça APA; Silva ILAFE; Caruso P
    Antimicrob Resist Infect Control; 2023 Feb; 12(1):8. PubMed ID: 36755339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.